Related Experiment Video
Updated: May 15, 2026

Investigating Drivers of Antireward in Addiction Behavior with Anatomically Specific Single-Cell Gene Expression Methods
Published on: August 4, 2022
Views on Psychedelic-Assisted Therapy for Substance Use Disorders from Individuals with Opioid Use Disorder and a
Veronica Szpak1, Samuel Maddams1, Amanda Kim1,2
1Department of Psychiatry, Brigham and Women's Hospital, Boston, Massachusetts, USA.
Objectives:
New treatment options are needed to improve outcomes for patients with both opioid use disorder (OUD) and injection-related infections. Psychedelic-assisted therapy (PAT) has been suggested as a potential treatment for substance use disorders (SUD). To address this need, a qualitative study was conducted to understand the attitudes toward PAT from individuals with OUD who have survived injection-related infections.
Methods:
Semistructured interviews were conducted with individuals with an OUD diagnosis and a history of an injection-related infection. A thematic analysis was performed on transcribed interviews.
Results:
Seventeen participants completed the interviews. The mean age was 43.8 years, and 58.8% were men. Participants generally expressed support for PAT for SUD; however, they also raised concerns. The most common themes that emerged were as follows: hospitalization allowed individuals to recognize the severity of their underlying OUD, PAT could contribute to greater insights about their illness and greater openness to recovery, comfort in knowing PAT will be administered while being monitored by qualified professionals, PAT addressing underlying mental health issues, and the importance of spirituality in recovery. The themes surrounding concerns involved experiencing a "bad trip," adverse effects, the risk of relapse, and psychedelic misuse.
Conclusions:
Overall, participants with OUD who survived injection-related infections view PAT positively as a treatment option for SUD. However, they have concerns about potential negative effects. Further research is needed to understand PAT acceptability for this patient population, especially if traditional medications for OUD have been ineffective.
More Related Videos
09:54Combining Laser Capture Microdissection and Microfluidic qPCR to Analyze Transcriptional Profiles of Single Cells: A Systems Biology Approach to Opioid Dependence
Published on: March 8, 2020
10:17High-throughput and Comprehensive Drug Surveillance Using Multisegment Injection-Capillary Electrophoresis-Mass Spectrometry
Published on: April 23, 2019
Related Concept Videos
Substance Use Disorders Affecting Sleep
Understanding the concepts of physical dependence,...
Drug Abuse and Addiction: Pharmacological Phenomena
Analgesia and Pain Management
CNS Stimulants: Psychedelic Agents
Drug Dependence
Drug Administration and Therapy Phases: Overview
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...